R.Narasimhan, R.Padmanaban, R.Gopal entered into an agreement to acquire additional 65% stake in SDS Ramcides Cropscience Private Limited from SDS Biotech K.K. (TSE:4952) for INR 0.21 million on March 13, 2018. Under the terms of the transaction, SDS Ramcides Cropscience Private Limited will also carry out a capital increase of 1.32 billion shares in SDS Ramcides Cropscience Private Limited and will hold 97.95% stake upon completion of capital increase. SDS Biotech K.K. will transfer 97.95% stake in SDS Ramcides Cropscience Private Limited at the closing. As a condition of the transaction, SDS Biotech K.K. will repay ¥2.2 billion (INR 1.4 billion) of guarantee obligation underwriting by third party allotment of new shares by SDS Ramcides and the remaining amount of ¥850 million (INR 517.9 million) through raising of funds and repay it under the responsibility of the three existing founders. For the year ended March 2017, SDS Ramcides Cropscience Private Limited reported total assets of ¥3.2 billion (INR 1.96 billion), net liabilities of ¥738.1 million (INR 449.67 million), revenue of ¥2.7 billion (INR 1.67 billion), operating loss of ¥421.5 million (INR 256.8 million), and net loss of ¥739.4 million (INR 450.5 million). The transaction was resolved by the Board of Directors of SDS Biotech K.K. on March 13, 2018. The capital increase is expected to close on March 15, 2018. The transaction is expected to close on March 27, 2018. R.Narasimhan, R.Padmanaban, R.Gopal completed the acquisition of an additional 97.95% stake in SDS Ramcides Cropscience Private Limited from SDS Biotech K.K. (TSE:4952) for INR 5.3 million on March 27, 2018.